{"entity":{"id":"wigen-biomedicine-technology-shanghai","kind":"company","name":"Wigen Biomedicine Technology (Shanghai)","aka":["Wigen Biomedicine Technology (Shanghai) Co., Ltd."],"tldr":"Wigen Biomedicine Technology (Shanghai) is a China-based biotechnology company running 2 late-stage cancer trials of WJB001.","summary":"Wigen Biomedicine Technology (Shanghai), based in Shanghai, China, is a biotechnology company. Wigen Biomedicine develops innovative anti-tumour drugs using small-molecule covalent/allosteric, PROTAC and drug-conjugate technology platforms. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials, testing WJB001. The largest, NCT05773820 (A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumours), plans to enrol 210 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.","asOf":"2026-09-11","links":[{"label":"Official website","url":"https://www.wigenbio.com"},{"label":"ClinicalTrials.gov: trials led by Wigen Biomedicine Technology (Shanghai)","url":"https://clinicaltrials.gov/search?lead=Wigen%20Biomedicine%20Technology%20(Shanghai)%20Co.%2C%20Ltd."}],"tags":["ctgov-sponsor"],"related":[],"cancers":[],"sections":[],"technologies":["protac-degrader"],"targets":[],"drugs":["wjb001"],"companies":[],"institutions":[],"pathways":[],"terms":["pivotal-trial","clinical-trial"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"provenance":{"editedBy":"OnCo ingestion (ClinicalTrials.gov v2 + sponsor websites)","editedOn":"2026-09-11"},"hq":"Shanghai","country":"CN","companyType":"biotech","website":"https://www.wigenbio.com","founded":2018,"stage":"growth","investors":[],"funding":[]},"route":"/companies/wigen-biomedicine-technology-shanghai/","neighbours":{"technology":[{"id":"protac-degrader","kind":"technology","name":"PROTACs & molecular glues (targeted protein degradation)","route":"/technologies/protac-degrader/"}],"drug":[{"id":"wjb001","kind":"drug","name":"WJB001","route":"/drugs/wjb001/"}],"term":[{"id":"clinical-trial","kind":"term","name":"Clinical trial","route":"/terms/clinical-trial/"},{"id":"pivotal-trial","kind":"term","name":"Pivotal (registrational) trial","route":"/terms/pivotal-trial/"}],"trial":[{"id":"nct06953323","kind":"trial","name":"A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors","route":"/trials/nct06953323/"},{"id":"nct05773820","kind":"trial","name":"A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors","route":"/trials/nct05773820/"}]}}